EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex

Caleb R Carr, Katharine H D Crawford, Michael Murphy, Jared G Galloway, Hugh K Haddox, Frederick A Matsen, Kristian G Andersen, Neil P King, Jesse D Bloom

Immunity · 2024

DOI: 10.1016/j.immuni.2024.06.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2024. Verfasst von Caleb R Carr und 8 weiteren Autor:innen. Beteiligte Einrichtung: Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Genome Sciences, Univ…. Hauptthemen laut MEDLINE: Lassa virus, Antibodies, Viral, Mutation, Antibodies, Neutralizing. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lassa virus is estimated to cause thousands of human deaths per year, primarily due to spillovers from its natural host, Mastomys rodents. Efforts to create vaccines and antibody therapeutics must account for the evolutionary variability of the Lassa virus's glycoprotein complex (GPC), which mediates viral entry into cells and is the target of neutralizing antibodies. To map the evolutionary space accessible to GPC, we used pseudovirus deep mutational scanning to measure how nearly all GPC amino-acid mutations affected cell entry and antibody neutralization. Our experiments defined functional constraints throughout GPC. We quantified how GPC mutations affected neutralization with a panel of monoclonal antibodies. All antibodies tested were escaped by mutations that existed among natural Lassa virus lineages. Overall, our work describes a biosafety-level-2 method to elucidate the mutational space accessible to GPC and shows how prospective characterization of antigenic variation could aid the design of therapeutics and vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa virusAntibodies, ViralMutationAntibodies, NeutralizingAntibodies, MonoclonalLassa FeverHumansAnimalsVirus InternalizationViral Envelope ProteinsGlycoproteinsImmune EvasionHEK293 Cells

Stichwörter der Autor:innen

ArevirumabArevirumab-3GPCLassa virusantibody escapeantigenic variationarena virusdeep mutational scanningglobal epistasis

Substanzen

Antibodies, ViralAntibodies, NeutralizingAntibodies, MonoclonalViral Envelope ProteinsGlycoproteins

Autor:innen und Institutionen

  • Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Medical Scientist Traini…
  • Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  • Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Statistics, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institu…
  • Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Scripps Research Translational Institute, La Jolla, CA 92037, USA.
  • Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical In…

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • Howard Hughes Medical Institute
  • NCATS NIH HHS
  • NIAID
  • National Institutes of Health
  • GlaxoSmithKline

Zitieren

APA

Carr, C. R., Crawford, K. H. D., Murphy, M., Galloway, J. G., Haddox, H. K., Matsen, F. A., Andersen, K. G., King, N. P., & Bloom, J. D. (2024). Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex. Immunity. https://doi.org/10.1016/j.immuni.2024.06.013

Vancouver

Carr CR, Crawford KHD, Murphy M, Galloway JG, Haddox HK, Matsen FA, et al. Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex. Immunity. 2024. doi:10.1016/j.immuni.2024.06.013

BibTeX
@article{Carr2024,
  author = {Carr, Caleb R and Crawford, Katharine H D and Murphy, Michael and Galloway, Jared G and Haddox, Hugh K and Matsen, Frederick A and Andersen, Kristian G and King, Neil P and Bloom, Jesse D},
  title = {Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex},
  journal = {Immunity},
  year = {2024},
  doi = {10.1016/j.immuni.2024.06.013}
}
Kostenlos starten →